Startseite>>Signaling Pathways>> Membrane Transporter/Ion Channel>> GABA Receptor>>p-Hydroxybenzaldehyde-d4

p-Hydroxybenzaldehyde-d4

Katalog-Nr.GC72723

p-Hydroxybenzaldehyde-d4 is the deuterium labeled p-Hydroxybenzaldehyde.

Products are for research use only. Not for human use. We do not sell to patients.

p-Hydroxybenzaldehyde-d4 Chemische Struktur

Cas No.: 284474-52-8

Größe Preis Lagerbestand Menge
5 mg
70,00 $
Auf Lager
10 mg
113,00 $
Auf Lager
25 mg
221,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
p-Hydroxybenzaldehyde-d4 is the deuterium labeled p-Hydroxybenzaldehyde. p-Hydroxybenzaldehyde is a one of the major components in Dendrocalamus asper bamboo shoots, with antagonistic effect on GABAA receptor of the α1β2γ2S subtype at high concentrations.

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

References:
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
[2]. Zhang J, et al. The Effect of 4-hydroxybenzaldehyde on the γ-aminobutyric Acid Type A Receptor. Malays J Med Sci. 2017 Mar;24(2):94-99.

Bewertungen

Review for p-Hydroxybenzaldehyde-d4

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for p-Hydroxybenzaldehyde-d4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.